Hormonal growth promotants (HGPs) are a group of veterinary medicines that pose
unique risks to New Zealand’s trade in primary produce. While it is legal to administer
HGPs to beef cattle in New Zealand, certain overseas countries have banned their use.
As New Zealand exports 80% of its beef produce, it became necessary to develop
regulatory controls to ensure HGP-treated beef is not sent to markets that only accept
non-HGP animal products.

An internationally accepted set of guidelines that describe proven systems/procedures for the production of quality for ACVM products.

This document specifies the minimum study and reporting requirements, i.e. the standard,
for efficacy studies submitted in support of an application to register an anticoccidial in
poultry, or to vary the conditions on a registered anticoccidial in poultry. It also
incorporates guidelines, which are intended to provide more detailed information and
guidance to applicants to assist them in complying with the standard.

This document specifies the minimum study and reporting requirements, i.e. the standard,
for efficacy studies submitted in support of an application to register an antihistamine
product, or to vary the conditions on a registered antihistamine product. It also
incorporates guidelines, which are intended to provide more detailed information and
guidance to applicants to assist them in complying with the standard.

This document specifies the minimum study and reporting requirements, i.e. the standard,
for efficacy studies submitted in support of an application to register an antispasmodic
product, or to vary the conditions on a registered antispasmodic product. It also
incorporates guidelines, which are intended to provide more detailed information and
guidance to applicants to assist them in complying with the standard.

This document specifies the minimum study and reporting requirements, i.e. the standard,
for efficacy studies submitted in support of an application to register a corticosteroid or
to vary the conditions on a registered corticosteroid. It also incorporates guidelines,
which are intended to provide more detailed information and guidance to applicants to
assist them in complying with the standard.

This document specifies the minimum study and reporting requirements, i.e. the standard,
for efficacy studies submitted in support of an application to register an emetic, or to
vary the conditions on a registered emetic. It also incorporates guidelines, which are
intended to provide more detailed information and guidance to applicants to assist them
in complying with the standard.

Efficacy of a veterinary medicine is understood to be the degree to which the medicinal
claims made by the applicant have been justified and are likely to be attained under
practical field conditions within New Zealand. The need for an efficacy standard arises
from section 4 of the Agricultural Compounds and Veterinay Medicines (ACVM) Act
1997, which provides for prevention or management of risks associated with the use of
agricultural compounds:
• risks to trade in primary produce; and
• risks to animal welfare; and
• risks to agricultural security.

This document specifies the minimum study and reporting requirements, i.e. the standard,
for efficacy studies submitted in support of an application to register a vaccine, or to
vary the conditions on a registered vaccine. It also incorporates guidelines, which are
intended to provide more detailed information and guidance to applicants to assist them
in complying with the standard.

This document specifies the minimum study and reporting requirements, i.e. the standard,
for efficacy studies submitted in support of an application to register a zinc prophylactic
product for facial eczema, or to vary the conditions on a registered zinc prophylactic
product for facial eczema. It also incorporates guidelines, which are intended to provide
more detailed information and guidance to applicants to assist them in complying with
the standard.

While some pain or distress to the animal is inevitable at times from administration of
a product, the intensity and duration must be no more than is necessary to prevent or
treat the condition concerned. Some recognition is therefore required of the extent of
suffering that may arise from the use of alternative products and the suffering that may
arise from not administering the product.

ACVM Requirement - Waiver of Fees, Charges and Levies for Agricultural Compounds and Veterinary Medicines

This is a quality assurance programme developed by the Ministry for Primary Industries (MPI). It aims to ensure that all veterinary medicines in the marketplace are safe, efficacious, of acceptable quality, used appropriately, and that product labels provide sufficient consumer information for correct use.

The purpose of the Agricultural Compounds and Veterinary Medicines (ACVM) Act 1997 is to:
(1) manage risks (public health, animal welfare, trade, agricultural security);
(2) ensure that the use of agricultural compounds does not result in breaches of domestic food residue standards;
(3) ensure the provision of sufficient consumer information about agricultural compounds.
Conditions are placed on product registrations to help achieve this purpose.